GlassScriptPhysician profile
Niambi Brown
NPI 1609166065
$2,002.84
in general payments reported to CMS, 2019-2025
26 companies · $565 in 2025
The $565 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2024: $1,174 · 2025: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,738.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $363.70 | 2024-2025 | General - Vascular Intervention, Bodyguardian, Lux-Dx Insertable Cardiac Monitor |
| Gilead Sciences, INC. | $264.38 | 2019 | |
| Novo Nordisk INC | $216.21 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $161.29 | 2024-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| Edwards Lifesciences Corporation | $145.14 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Exact Sciences Corporation | $96.78 | 2024-2025 | Cologuard Collection Kit |
| Irhythm Technologies, INC. | $85.88 | 2024 | Zio Monitor, Zio Xt Patch |
| Pfizer INC. | $69.62 | 2024 | |
| Glaxosmithkline, LLC. | $67.61 | 2025 | Shingrix, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.04 | 2024-2025 | Jardiance |
| Abbvie INC. | $63.13 | 2024 | |
| Hologic Sales and Service, LLC | $46.13 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Inspire Medical Systems, INC. | $43.49 | 2024-2025 | Inspire |
| Dexcom, INC. | $42.37 | 2024-2025 | Dexcom G6 Transmitter |
| Kestra Medical Technology Services, INC. | $35.56 | 2024 | Assure Wcd |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $33.26 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Abiomed | $26.63 | 2025 | |
| Sanofi-Aventis U.S. LLC | $25.30 | 2025 | |
| Axsome Therapeutics, INC. | $24.66 | 2025 | Symbravo |
| Terumo Medical Corporation | $22.63 | 2024 | R2p Misago, Metacross Otw, Glidesheath Slender |
| Astellas Pharma US INC | $21.99 | 2025 | Veozah |
| Lilly USA, LLC | $19.63 | 2024 | Mounjaro |
| Janssen Pharmaceuticals, INC | $17.16 | 2024 | Xarelto |
| Sanofi Pasteur INC. | $15.27 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $15.06 | 2024 | Breztri |
| Esperion Therapeutics, INC. | $13.92 | 2024 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niambi Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.